Literature DB >> 18194414

Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal.

D Poli, E Antonucci, G Ciuti, R Abbate, D Prisco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18194414     DOI： 10.1111/j.1538-7836.2008.02900.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  14 in total

Review 1.  Update in general internal medicine.

Authors:  Toshiko Uchida; Stephen D Persell; David W Baker
Journal:  J Gen Intern Med       Date:  2009-10-28       Impact factor: 5.128

2.  Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence.

Authors:  Cristina Legnani; Michela Cini; Benilde Cosmi; Paolo Carraro; Armando Tripodi; Nicoletta Erba; Gualtiero Palareti
Journal:  Intern Emerg Med       Date:  2011-05-17       Impact factor: 3.397

3.  Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism.

Authors:  Daniela Poli; Elisa Grifoni; Emilia Antonucci; Chiara Arcangeli; Domenico Prisco; Rosanna Abbate; Massimo Miniati
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

Review 4.  Which patients with unprovoked VTE should receive extended anticoagulation? the minority.

Authors:  Marco P Donadini; Walter Ageno
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

5.  Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study.

Authors:  Bruna M Mazetto; Fernanda L A Orsi; Sandra A F Silveira; Luis F Bittar; Mariane M C Flores-Nascimento; Kiara C S Zapponi; Marina P Colella; Erich V de Paula; Joyce M Annichino-Bizzacchi
Journal:  Clin Appl Thromb Hemost       Date:  2017-04-10       Impact factor: 2.389

6.  Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer.

Authors:  F Dentali; S Barco; S Pegoraro; M N D Di Minno; D Mastroiacovo; F Pomero; C Lodigiani; F Bagna; M Sartori; G Barillari; N Mumoli; M Napolitano; S M Passamonti; R Benedetti; W Ageno; M Di Nisio
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

Review 7.  Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.

Authors:  James Douketis; Alberto Tosetto; Maura Marcucci; Trevor Baglin; Benilde Cosmi; Mary Cushman; Paul Kyrle; Daniela Poli; R Campbell Tait; Alfonso Iorio
Journal:  BMJ       Date:  2011-02-24

8.  Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis.

Authors:  Aaron B Holley; Christopher S King; Jeffrey L Jackson; Lisa K Moores
Journal:  Thrombosis       Date:  2010-12-29

9.  Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.

Authors:  H Cohen; C J Doré; S Clawson; B J Hunt; D Isenberg; M Khamashta; N Muirhead
Journal:  Lupus       Date:  2015-05-04       Impact factor: 2.911

10.  Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approach.

Authors:  Maura Marcucci; Alfonso Iorio; James Douketis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.